CD8A and neoplasm: In preclinical mouse models, ALRN-6924 has shown activity as a radio-protectant that also prevents chemotherapy-induced toxicity.217,395,396 It has also been shown to promote the recruitment of tumor-infiltrating immune cells, especially CD8+ killer T cells, and increase tumor-suppressing M1 macrophages.